Forum on drug review and approval policy was successfully concluded

Date:2018-08-29Hit:

     On the afternoon of August 24, 2018, the Forum on Drug Examination, Assessment and Approval Policy Interpretation sponsored by Wuhan National Bioindustry Base Construction Management Office, Wuhan Donghu National Independent Innovation Demonstration Zone Biomedicine Industry Association, and Hubei Topgene Biotechnology Co., Ltd. was held in the conference hall of Erfei Mountain Resort Guanggu. The meeting invited experts of national new drug approval, leaders of provincial drug regulatory bureau and entrepreneurs'representatives to interpret the policy of drug approval and approval. It attracted nearly 60 units and enterprises from Hubei CDC, Renfu Medicine, Xikang Biology, Youzhiyou and Yuanda Medicine to participate in the exchange.


     Dong Huili, Vice Director of Biology Office, Wang Xuehai, Chairman of Renfu Group, and Ma Chunhui, General Manager of Topgene Biology attended and addressed the meeting.

     At the meeting, Professor Sun Zuyue, member of CFDA New Drug Review Advisory Committee, New Drug Review Expert, Director Du Hanye of Hubei Food and Drug Administration Registry, and Director Li Jihong of Hubei Topgene Biotechnology Wuhan Branch made brilliant remarks on the reform of drug review and approval system, common technical defects in drug review and prevention measures. The speech brought a full share of dry goods.



Dong Huili, deputy director of biology office, delivered a speech



Wang Xuehai, chairman of human welfare Pharmaceutical Group, delivered a speech.


Ma Chunhui, general manager of Topgene, delivered a speech.


Professor Sun Zuyue, member of the CFDA New Drug Review Advisory Committee and expert on New Drug Review, delivered a speech on "Common Technical Defects and Preventive Measures in Drug Review"



Director Du Hanye of the Registry of Hubei Food and Drug Administration delivered a speech on the reform of the drug examination and approval system and answered questions on the spot.




Li Jihong, director of Topgene Biotechnology Wuhan branch, introduces the basic situation of Topgene biology.



     The meeting ended perfectly after the participants'enthusiastic questioning and in-depth discussion, and won the unanimous praise of the representatives of the participating enterprises on the spot. The meeting ended successfully.



姚记棋牌所有app 北京时时彩的官网下载 管家婆六肖期期中 极速赛车精准计划 湖北十一选五前三走势图 贵州11选5动先走势图 a1107幸运28抽奖源码 028湖南快乐十分 000032股票行情 分分彩是不是正规的 每日三支股票推荐